Clinical trial
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
NCT06478602 is registered in ClinicalTrials.gov with Cristian Ichim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
- Lead sponsor
- Cristian Ichim
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 5, 2024
- Completion date
- March 31, 2025
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.